First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Short Interest Update

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) was the recipient of a significant growth in short interest during the month of January. As of January 15th, there was short interest totaling 55,046 shares, a growth of 53.6% from the December 31st total of 35,837 shares. Approximately 0.8% of the company’s shares are short sold. Based on an average daily volume of 38,396 shares, the days-to-cover ratio is currently 1.4 days. Based on an average daily volume of 38,396 shares, the days-to-cover ratio is currently 1.4 days. Approximately 0.8% of the company’s shares are short sold.

First Trust NYSE Arca Biotechnology Index Fund Trading Down 1.9%

NYSEARCA:FBT traded down $4.09 during trading hours on Friday, hitting $212.93. 57,173 shares of the company were exchanged, compared to its average volume of 427,959. First Trust NYSE Arca Biotechnology Index Fund has a one year low of $141.38 and a one year high of $224.94. The stock has a market capitalization of $223.58 million, a price-to-earnings ratio of 21.72 and a beta of 0.65. The company has a fifty day simple moving average of $212.76 and a 200 day simple moving average of $191.35.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Janney Montgomery Scott LLC raised its position in First Trust NYSE Arca Biotechnology Index Fund by 1.4% in the 2nd quarter. Janney Montgomery Scott LLC now owns 28,270 shares of the company’s stock valued at $4,561,000 after buying an additional 382 shares during the last quarter. Truist Financial Corp grew its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 12.8% during the 2nd quarter. Truist Financial Corp now owns 45,234 shares of the company’s stock worth $7,298,000 after acquiring an additional 5,136 shares during the period. Berger Financial Group Inc lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 1.8% during the second quarter. Berger Financial Group Inc now owns 113,019 shares of the company’s stock valued at $18,233,000 after purchasing an additional 2,045 shares during the last quarter. RMG Wealth Management LLC purchased a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the 2nd quarter valued at approximately $80,000. Finally, Robertson Stephens Wealth Management LLC lifted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 18.6% during the second quarter. Robertson Stephens Wealth Management LLC now owns 3,677 shares of the company’s stock worth $593,000 after acquiring an additional 576 shares in the last quarter.

About First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.